Lushang Freda Pharmaceutical Co., Ltd. Class ASSE: 600223

Announcement on "Corporate Value and Return Enhancement" Action Plan 2025

· Issued by Lushang Freda Pharmaceutical Co., Ltd. Class A via Shanghai Stock Exchange
Announcement on "Corporate Value and Return Enhancement" Action Plan 2025

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment